SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (6974)8/24/1998 1:26:00 AM
From: Webhead  Read Replies (1) | Respond to of 17367
 
Here's a repost of a link from the Ligand thread describing orphan drug status. From a quick read it looks like the 50% tax writeoff of clinical trial costs will be the most significant help to XOMA.

Still, I could have stood one less "buying opportunity"!
Ed

fda.gov



To: Bluegreen who wrote (6974)8/25/1998 6:56:00 AM
From: Robert K.  Read Replies (2) | Respond to of 17367
 
Did anyone notice the trade at about 3:18 pm est yesterday?
Looked like a "over" 200,000 share block (bought and sold).
Hey george, was that you? VBG.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News